Work

Asthma Outcomes in Pediatric Patients Utilizing XOLAIR (Omalizumab) in a Commercially Insured Population in the United States

Year: 2021

Type: conference-abstract

Source: American Journal of Respiratory and Critical Care Medicine

DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1466

Authors: P. Sullivan, Y. Ghaedsharaf, Z. Zheng, N. Mumneh, B. Ndife

Institutions: Regis University, Novartis (United States)

Language: English

Topic: Asthma and respiratory diseases

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3159826186

Cites:

Cited by:

Related to: 10